Global melatonin market demand is expected to grow on account of increasing food & beverage and construction industries in emerging economies including China, India and Brazil. In addition, the market is also driven by its applications in pharmaceutical and dietary supplement products. Absence of strict government regulations aimed at restricting use of the compound is expected to favor market growth. However, controversies regarding the possible side effects on consumption of melatonin in humans are anticipated to act as a key restraining factor for this market. Volatility in prices of raw materials is also expected to restrain market growth. Use of energy-efficient lighting known to suppress melatonin secretion levels in humans is likely to open new market avenues for melatonin supplement products over the forecast period.
Melatonin is an artificially manufactured form of hormone present in plants, animals, bacteria and fungi. Owing to its antioxidant properties, melatonin finds application in food & beverages, pharmaceuticals and dietary supplements. Melatonin is also used in the manufacture of bio-based spray polyurethane foam (SPF), which is used in building insulation. SPF exhibits improved insulation properties as compared to traditional insulators such as fiberglass resulting in lower heating or cooling costs. The aforementioned factor is expected to fuel the melatonin market in the upcoming years.
Major market share for melatonin was held by pharmaceuticals in 2013 owing to its use for treating sleeping disorders and its sedating & calming effect. Construction industry is expected to witness fastest growth rate owing to increasing use of melatonin in SPF manufacture as a replacement for traditional building insulators such as natural fiber and fiberglass.
North America accounted for major market share of melatonin market in light of high use of dietary supplements and SPF in construction activities in the region. Asia Pacific is expected to witness high growth over the forecast period on account of rapid industrialization and growing construction and pharmaceutical sectors in emerging economies such as China and India. European markets are anticipated to witness sluggish growth on account of slow recovery from recession. Emerging economies such as China, India and Brazil are likely to be a more lucrative market owing to the large end-user base along with lower investments in land and labor.
Global melatonin market is fragmented in nature with major share being held by a few major companies. Key players of the melatonin market are BASF, Aspen Pharmacare Holdings, NCFI Polyurethanes, Lapolla Industries, The Dow Chemical Company, Flynn Pharma and Natrol.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.